Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Levetiracetam Patent Expiration

Levetiracetam was first introduced by Ucb Inc in its drug Keppra on Nov 30, 1999. Other drugs containing Levetiracetam are Spritam, Levetiracetam In Sodium Chloride, Elepsia Xr, Keppra Xr. 79 different companies have introduced drugs containing Levetiracetam.


Levetiracetam Patents

Given below is the list of patents protecting Levetiracetam, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Spritam US11160786 Rapid disperse dosage form Mar 14, 2034 Aprecia Pharms
Spritam US9339489 Rapid disperse dosage form containing levetiracetam Mar 14, 2034 Aprecia Pharms
Spritam US9669009 Rapid disperse dosage form containing levetiracetam Mar 14, 2034 Aprecia Pharms
Keppra US8802142

(Pediatric)

 Pharmaceutical compositions comprising levetiracetam and process for their preparation Dec 07, 2031 Ucb Inc
Keppra US8802142 Pharmaceutical compositions comprising levetiracetam and process for their preparation Jun 07, 2031 Ucb Inc
Keppra Xr US7858122 Extended release formulation of levetiracetam Sep 17, 2028 Ucb Inc
Elepsia Xr US8431156 Pharmaceutical composition Oct 31, 2027 Tripoint
Elepsia Xr US8470367 Oral drug delivery system Oct 31, 2027 Tripoint
Elepsia Xr US8163306 Oral drug delivery system Sep 03, 2027 Tripoint
Elepsia Xr US8425938 Pharmaceutical composition Feb 22, 2026 Tripoint
Elepsia Xr US8535717 Pharmaceutical composition Feb 22, 2026 Tripoint
Spritam US6471992 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same Feb 20, 2018

(Expired)

 Aprecia Pharms
Spritam US9463160 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same Feb 20, 2018

(Expired)

 Aprecia Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Levetiracetam's patents.

Given below is the list recent legal activities going on the following patents of Levetiracetam.

Activity Date Patent Number
Patent litigations
Post Issue Communication - Certificate of Correction 26 Jan, 2022 US11160786
Patent Issue Date Used in PTA Calculation
Critical
 02 Nov, 2021 US11160786
Recordation of Patent Grant Mailed
Critical
 02 Nov, 2021 US11160786
Email Notification
Critical
 14 Oct, 2021 US11160786
Issue Notification Mailed
Critical
 13 Oct, 2021 US11160786
Application Is Considered Ready for Issue
Critical
 01 Oct, 2021 US11160786
Dispatch to FDC 01 Oct, 2021 US11160786
Issue Fee Payment Verified
Critical
 28 Sep, 2021 US11160786
Issue Fee Payment Received
Critical
 28 Sep, 2021 US11160786
Email Notification
Critical
 01 Sep, 2021 US11160786


Levetiracetam's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Levetiracetam Generic API Manufacturers

Several generic applications have been filed for Levetiracetam. The first generic version for Levetiracetam was by Mylan Pharmaceuticals Inc and was approved on Nov 4, 2008. And the latest generic version is by B Braun Medical Inc and was approved on Feb 27, 2024.

Given below is the list of companies who have filed for Levetiracetam generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet Discontinued ORAL N/A Feb 14, 2011
250MG

tablet Discontinued ORAL N/A Feb 14, 2011
750MG

tablet Discontinued ORAL N/A Feb 14, 2011
1GM

tablet Discontinued ORAL N/A Feb 14, 2011





2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Discontinued ORAL N/A Sep 12, 2011
500MG

tablet, extended release Discontinued ORAL N/A Sep 12, 2011


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





3. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 3 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Prescription ORAL AB Sep 12, 2011
250MG

tablet Discontinued ORAL N/A Mar 2, 2009
750MG

tablet, extended release Prescription ORAL AB Sep 12, 2011





4. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Jan 15, 2009





5. ADAPTIS

Adaptis Pharma Private Ltd has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Adaptis.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Discontinued ORAL N/A Sep 4, 2015
500MG

tablet, extended release Discontinued ORAL N/A Sep 4, 2015





6. AIPING PHARM INC

Aiping Pharmaceutical Inc has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Prescription ORAL AB Aug 26, 2016
750MG

tablet, extended release Prescription ORAL AB Aug 26, 2016





7. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA May 9, 2013


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)





8. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM

tablet Prescription ORAL AB May 27, 2022
250MG

tablet Prescription ORAL AB May 27, 2022
500MG

tablet Prescription ORAL AB May 27, 2022
750MG

tablet Prescription ORAL AB May 27, 2022





9. AM REGENT

American Regent Inc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Am Regent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Discontinued INTRAVENOUS N/A Jan 31, 2012





10. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Oct 27, 2009





11. ANDA REPOSITORY

Anda Repository Llc has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Anda Repository.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Prescription ORAL AB Feb 23, 2016
500MG

tablet, extended release Prescription ORAL AB Feb 23, 2016





12. APOTEX

Apotex Inc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM

tablet, extended release Prescription ORAL N/A Feb 25, 2015


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
Brantford Apotex Pharmachem Inc.
Etobicoke Apotex, Inc.
Winnipeg Apotex Fermentation Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





13. APOTEX INC

Apotex Inc has filed for 3 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Discontinued ORAL N/A Aug 5, 2011
500MG

tablet, extended release Prescription ORAL AB Sep 12, 2011
750MG

tablet, extended release Prescription ORAL AB Sep 12, 2011


Manufacturing Plant Locations
New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country City Firm Name
Canada
Toronto Apotex Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.





14. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet Prescription ORAL AB Jan 15, 2009
100MG/ML

solution Prescription ORAL AA Jan 15, 2009
250MG

tablet Prescription ORAL AB Jan 15, 2009
500MG

tablet Prescription ORAL AB Jan 15, 2009
1GM

tablet Prescription ORAL AB Jan 15, 2009


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





15. AUROBINDO PHARMA USA

Aurobindo Pharma Usa Inc has filed for 3 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Discontinued ORAL N/A Dec 19, 2011
750MG

tablet, extended release Discontinued ORAL N/A Dec 19, 2011
1GM

tablet, extended release Discontinued ORAL N/A Dec 7, 2015


Manufacturing Plant Locations
New

Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.

Country City Firm Name
United States
East Windsor Aurobindo Pharma USA Inc





16. B BRAUN MEDICAL INC

B Braun Medical Inc has filed for 3 different strengths of generic version for Levetiracetam. All of these versions come by the name LEVETIRACETAM IN SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by B Braun Medical Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5GM/100ML (15MG/ML)

injectable Prescription INTRAVENOUS AP Feb 27, 2024
500MG/100ML (5MG/ML)

injectable Prescription INTRAVENOUS AP Feb 27, 2024
1GM/100ML (10MG/ML)

injectable Prescription INTRAVENOUS AP Feb 27, 2024


Manufacturing Plant Locations
New

B Braun Medical Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of B Braun Medical Inc as present at those locations.

Country City Firm Name
United States
Breinigsville B Braun Medical Inc





17. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 3 different strengths of generic version for Levetiracetam. All of these versions come by the name LEVETIRACETAM IN SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/100ML (5MG/ML)

injectable Prescription INTRAVENOUS AP Oct 2, 2023
1.5GM/100ML (15MG/ML)

injectable Prescription INTRAVENOUS AP Oct 2, 2023
1GM/100ML (10MG/ML)

injectable Prescription INTRAVENOUS AP Oct 2, 2023





18. BELCHER

Belcher Pharmaceuticals Llc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Belcher.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Sep 30, 2010


Manufacturing Plant Locations
New

Belcher's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Belcher as present at those locations.

Country City Firm Name
United States
Largo Belcher Pharmaceuticals, LLC





19. BIONPHARMA

Bionpharma Inc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Jan 16, 2009


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





20. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Apr 3, 2009





21. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Discontinued ORAL N/A Sep 12, 2011
250MG

tablet Prescription ORAL AB Jun 14, 2011
1GM

tablet Prescription ORAL AB Jun 14, 2011
750MG

tablet, extended release Discontinued ORAL N/A Sep 12, 2011





22. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Prescription ORAL AB Jan 15, 2009
500MG

tablet Prescription ORAL AB Jan 15, 2009
750MG

tablet Prescription ORAL AB Jan 15, 2009
1GM

tablet Prescription ORAL AB Jan 15, 2009





23. ENDO OPERATIONS

Endo Operations Ltd has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Discontinued ORAL N/A Oct 4, 2011
500MG

tablet, extended release Discontinued ORAL N/A Oct 4, 2011





24. EPIC PHARMA LLC

Epic Pharma Llc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Discontinued INTRAVENOUS N/A May 4, 2018





25. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 4 different strengths of generic version for Levetiracetam. Out of these 500mg/100ml (5mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE, 1.5gm/100ml (15mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE, 1gm/100ml (10mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Feb 1, 2016
500MG/100ML (5MG/ML)

injectable Prescription INTRAVENOUS AP Jan 4, 2017
1.5GM/100ML (15MG/ML)

injectable Prescription INTRAVENOUS AP Jan 4, 2017
1GM/100ML (10MG/ML)

injectable Prescription INTRAVENOUS AP Jan 4, 2017


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Riico Industrial Area EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited





26. FOSUN PHARMA

Fosun Pharma Usa Inc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Fosun Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Discontinued ORAL N/A Jan 15, 2009
500MG

tablet Discontinued ORAL N/A Jan 15, 2009
750MG

tablet Discontinued ORAL N/A Jan 15, 2009
1GM

tablet Discontinued ORAL N/A Jan 15, 2009


Manufacturing Plant Locations
New

Fosun Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fosun Pharma as present at those locations.

Country City Firm Name
United States
Princeton Fosun Pharma USA Inc.





27. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 4 different strengths of generic version for Levetiracetam. Out of these 1gm/100ml (10mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE, 500mg/100ml (5mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE, 1.5gm/100ml (15mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Aug 13, 2015
1GM/100ML (10MG/ML)

injectable Discontinued INTRAVENOUS N/A Jan 31, 2023
500MG/100ML (5MG/ML)

injectable Discontinued INTRAVENOUS N/A Jan 31, 2023
1.5GM/100ML (15MG/ML)

injectable Discontinued INTRAVENOUS N/A Jan 31, 2023


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC





28. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 3 different strengths of generic version for Levetiracetam. All of these versions come by the name LEVETIRACETAM IN SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM/100ML (10MG/ML)

injectable Prescription INTRAVENOUS AP Oct 25, 2017
500MG/100ML (5MG/ML)

injectable Prescription INTRAVENOUS AP Oct 25, 2017
1.5GM/100ML (15MG/ML)

injectable Prescription INTRAVENOUS AP Oct 25, 2017





29. GRANULES

Granules India Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet Discontinued ORAL N/A Jun 13, 2023
1GM

tablet Discontinued ORAL N/A Jun 13, 2023
250MG

tablet Discontinued ORAL N/A Jun 13, 2023
750MG

tablet Discontinued ORAL N/A Jun 13, 2023


Manufacturing Plant Locations
New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country City Firm Name
United States
Manassas Granules Consumer Health Inc.
Chantilly Granules Pharmaceuticals Inc.
India
Parawada Mandal Granules India Limited
Sangareddy District Granules India Limited
Secunderabad Granules India Limited
Medchal-Malkhajgiri District Granules India Limited
Visakhapatnam Granules India Limited





30. HAINAN POLY PHARM

Hainan Poly Pharmaceutical Co Ltd has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Hainan Poly Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Mar 20, 2018


Manufacturing Plant Locations
New

Hainan Poly Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hainan Poly Pharm as present at those locations.

Country City Firm Name
China
Haikou Hainan Poly Pharm. Co., Ltd.





31. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 5 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet Prescription ORAL AB Oct 8, 2010
250MG

tablet Prescription ORAL AB Oct 8, 2010
750MG

tablet Prescription ORAL AB Oct 8, 2010
1GM

tablet Prescription ORAL AB Oct 8, 2010
100MG/ML

solution Prescription ORAL AA Feb 28, 2013





32. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Levetiracetam. Out of these 1gm/100ml (10mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE, 1.5gm/100ml (15mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE, 500mg/100ml (5mg/ml) version comes by the name LEVETIRACETAM IN SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Discontinued ORAL N/A Feb 28, 2012
1GM/100ML (10MG/ML)

injectable Prescription INTRAVENOUS AP Feb 12, 2024
1.5GM/100ML (15MG/ML)

injectable Prescription INTRAVENOUS AP Feb 12, 2024
500MG/100ML (5MG/ML)

injectable Prescription INTRAVENOUS AP Feb 12, 2024


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





33. HIKMA FARMACEUTICA

Hikma Farmaceutica (portugal) Sa has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Hikma Farmaceutica.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Oct 13, 2011


Manufacturing Plant Locations
New

Hikma Farmaceutica's manufacturing plants are situated in 1 country - Portugal. Given below are the details of these plant locations as well as the firm names of Hikma Farmaceutica as present at those locations.

Country City Firm Name
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.





34. HISUN PHARM HANGZHOU

Hisun Pharmaceutical (hangzhou) Co Ltd has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Hisun Pharm Hangzhou.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Prescription ORAL AB Sep 28, 2017
500MG

tablet, extended release Prescription ORAL AB Sep 28, 2017





35. HOSPIRA INC

Hospira Inc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Hospira Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Apr 6, 2012


Manufacturing Plant Locations
New

Hospira Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Hospira Inc as present at those locations.

Country City Firm Name
United States
Lake Forest Hospira Inc
Morgan Hill Hospira Inc





36. INGENUS PHARMS LLC

Ingenus Pharmaceuticals Llc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Ingenus Pharms Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Prescription ORAL AB Jan 15, 2009
500MG

tablet Prescription ORAL AB Jan 15, 2009
1GM

tablet Prescription ORAL AB Jan 15, 2009
750MG

tablet Prescription ORAL AB Jan 15, 2009





37. INVAGEN PHARMS

Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Invagen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Discontinued ORAL N/A Jan 15, 2009
500MG

tablet Discontinued ORAL N/A Jan 15, 2009
750MG

tablet Discontinued ORAL N/A Jan 15, 2009





38. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Discontinued INTRAVENOUS N/A Jun 2, 2016


Manufacturing Plant Locations
New

Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.

Country City Firm Name
India
Roorkee Jubilant Generics Limited





39. LOTUS PHARM CO LTD

Lotus Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Lotus Pharm Co Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Discontinued ORAL N/A Jun 6, 2016
750MG

tablet Discontinued ORAL N/A Oct 31, 2016
1GM

tablet Discontinued ORAL N/A Oct 31, 2016
250MG

tablet Discontinued ORAL N/A Oct 31, 2016





40. LUPIN

Lupin Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM

tablet Prescription ORAL AB Jan 15, 2009
250MG

tablet Prescription ORAL AB Jan 15, 2009
500MG

tablet Prescription ORAL AB Jan 15, 2009
750MG

tablet Prescription ORAL AB Jan 15, 2009


Manufacturing Plant Locations
New

Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.

Country City Firm Name
India
Navi Mumbai LUPIN LIMITED
Mandideep Lupin Limited (Unit II)
Vasco Da Gama Lupin Limited
Pithampur Lupin Limited
Aurangabad Lupin Ltd.
Pirangut Lupin Limited
Pithampur Lupin Limited (Unit 1)
Tarapur, Thane Lupin Limited
Anakapalli District Lupin Manufacturing Solutions Limited
Mumbai Lupin Limited
Mandideep Lupin Limited
Dabhasa LUPIN MANUFACTURING SOLUTIONS LIMITED
Nagpur Lupin Limited
Pune Lupin Bioresearch Center
United States
Baltimore Lupin Pharmaceuticals Inc.
Coral Springs Lupin Research Inc





41. LUPIN LTD

Lupin Ltd has filed for 3 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Prescription ORAL AB Sep 12, 2011
750MG

tablet, extended release Prescription ORAL AB Sep 12, 2011
100MG/ML

solution Prescription ORAL AA Oct 17, 2011


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





42. MICRO LABS

Micro Labs Ltd has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Aug 9, 2019


Manufacturing Plant Locations
New

Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.

Country City Firm Name
India
Bangalore Micro Labs Limited
Verna Micro Labs Limited
Bengaluru Micro Labs Limited, Central Analytical Laboratory
Bengaluru Micro Labs Limited





43. MSN

Msn Laboratories Private Ltd has filed for 6 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Jul 15, 2022
750MG

tablet Prescription ORAL AB Oct 7, 2022
1GM

tablet Prescription ORAL AB Oct 7, 2022
250MG

tablet Prescription ORAL AB Oct 7, 2022
500MG

tablet Prescription ORAL AB Oct 7, 2022
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Nov 15, 2022


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Kamareddy MSN Life Sciences Private Limited
Sangareddy MSN Pharmachem Private Limited
Rangareddy District MSN Laboratories Private Limited
Sangareddy MSN Laboratories Private Limited, R&D Center
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Yadadri Bhuvanagiri District MSN Organics Private Limited
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Sangareddy MSN Laboratories Private Ltd.
Isnapur MSN Laboratories Private Limited, Unit-II
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
United States
Piscataway MSN PHARMACEUTICALS INC





44. MYLAN

Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet Discontinued ORAL N/A Feb 10, 2009
250MG

tablet Discontinued ORAL N/A Feb 10, 2009
750MG

tablet Discontinued ORAL N/A Feb 10, 2009
1GM

tablet Prescription ORAL AB Dec 8, 2009


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Rockford Mylan Institutional, Inc.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos Mylan Pharmaceuticals Inc.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Morgantown Mylan Specialty, L.P.
Saint Albans Mylan Technologies, Inc.
Greensboro Mylan Pharmaceuticals Inc
India
Hyderabad Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





45. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Sep 16, 2016





46. NEXUS

Nexus Pharmaceuticals Llc has filed for 3 different strengths of generic version for Levetiracetam. All of these versions come by the name LEVETIRACETAM IN SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Nexus.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM/100ML (10MG/ML)

injectable Prescription INTRAVENOUS AP Jul 6, 2020
1.5GM/100ML (15MG/ML)

injectable Prescription INTRAVENOUS AP Jul 6, 2020
500MG/100ML (5MG/ML)

injectable Prescription INTRAVENOUS AP Jul 6, 2020


Manufacturing Plant Locations
New

Nexus's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Nexus as present at those locations.

Country City Firm Name
United States
Pleasant Prairie Nexus Pharmaceuticals Inc
Cottonwood Heights Nexus CMF, LLC
Lincolnshire Nexus Pharmaceuticals, LLC
Le Roy Nexus Cooperative
Bedford Park Nexus Distribution Corporation
Adams Nexus Cooperative
Santa Fe Springs Nexus Foods, Inc.
Cerritos Nexus Foods Inc
Emmons Nexus Cooperative
Lansing Nexus Cooperative
Bedford Park Nexus Distribution Corp.
Lenexa Nexus Medical LLC
Rose Creek Nexus Cooperative
San Diego Nexus Dx, Inc
Conger Nexus Cooperative
Alden Nexus Cooperative
Salt Lake City Nexus Spine, LLC
Brownsdale Nexus Cooperative





47. NOSTRUM LABS INC

Nostrum Laboratories Inc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Discontinued ORAL N/A Aug 18, 2011
500MG

tablet Discontinued ORAL N/A Aug 18, 2011
750MG

tablet Discontinued ORAL N/A Aug 18, 2011
1GM

tablet Discontinued ORAL N/A Aug 18, 2011





48. ORBION PHARMS

Orbion Pharmaceuticals Private Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Orbion Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Prescription ORAL AB Jan 15, 2009
500MG

tablet Prescription ORAL AB Jan 15, 2009
750MG

tablet Prescription ORAL AB Jan 15, 2009
1GM

tablet Prescription ORAL AB Aug 5, 2010





49. OVERSEAS

Overseas Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Overseas.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Prescription ORAL AB Jun 11, 2020
500MG

tablet, extended release Prescription ORAL AB May 5, 2023


Manufacturing Plant Locations
New

Overseas's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Overseas as present at those locations.

Country City Firm Name
United States
Vernon Overseas Food Distribution LLC
Fort Lee Overseas Food Trading Ltd.





50. OXFORD PHARMS

Oxford Pharmaceuticals Llc has filed for 3 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Oxford Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Prescription ORAL AB Mar 20, 2009
500MG

tablet Prescription ORAL AB Mar 20, 2009
750MG

tablet Prescription ORAL AB Mar 20, 2009





51. PHARM ASSOC

Pharmaceutical Associates Inc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Pharm Assoc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Jun 4, 2015





52. PHARMADAX INC

Pharmadax Inc has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Pharmadax Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Discontinued ORAL N/A May 25, 2012
500MG

tablet, extended release Discontinued ORAL N/A May 25, 2012


Manufacturing Plant Locations
New

Pharmadax Inc's manufacturing plants are situated in 1 country - Taiwan. Given below are the details of these plant locations as well as the firm names of Pharmadax Inc as present at those locations.

Country City Firm Name
Taiwan
New Taipei City Pharmadax Inc.





53. PHARMOBEDIENT CNSLTG

Pharmobedient Consulting has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Discontinued ORAL N/A Mar 3, 2010





54. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 5 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Prescription ORAL AB May 21, 2015
1GM

tablet Prescription ORAL AB Feb 10, 2009
500MG

tablet, extended release Prescription ORAL AB May 21, 2015
250MG

tablet Prescription ORAL AB Feb 10, 2009
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Mar 28, 2022





55. QUAGEN

Quagen Pharmaceuticals Llc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Quagen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Apr 11, 2012


Manufacturing Plant Locations
New

Quagen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Quagen as present at those locations.

Country City Firm Name
United States
West Caldwell Quagen Pharma, LLC
West Caldwell Quagen Pharmacuticals, LLC





56. RISING

Rising Pharma Holdings Inc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM

tablet Prescription ORAL AB Jul 28, 2010
750MG

tablet Prescription ORAL AB Jul 28, 2010
500MG

tablet Prescription ORAL AB Jul 28, 2010
250MG

tablet Prescription ORAL AB Jul 28, 2010


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Phoenix Rising Sun Farms Inc
Fort Bragg Rising Tide Sea Vegetables
Saddle Brook Rising Pharmaceuticals, Inc.
Decatur Rising Pharma Holdings, Inc
Livingston Risingsun Iodine Products Corp.
East Brunswick Rising Pharma Holding, Inc.
Mount Morris Rising Creek Bakery LLC
Rising Sun Rising Sun Veterinary Clinic
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





57. ROUSES POINT PHARMS

Rouses Point Pharmaceuticals Llc has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Rouses Point Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Discontinued ORAL N/A Aug 27, 2012
500MG

tablet, extended release Discontinued ORAL N/A Aug 27, 2012





58. SAGENT PHARMS

Sagent Pharmaceuticals Inc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Sagent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Jun 26, 2013





59. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Discontinued ORAL N/A Nov 1, 2012
750MG

tablet, extended release Discontinued ORAL N/A Nov 1, 2012


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited





60. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet Prescription ORAL AB Jun 11, 2021
500MG

tablet Prescription ORAL AB May 27, 2022
1GM

tablet Prescription ORAL AB Jun 11, 2021
250MG

tablet Prescription ORAL AB May 27, 2022





61. SECAN PHARMS

Secan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Secan Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM

tablet Discontinued ORAL N/A Dec 16, 2015
750MG

tablet Prescription ORAL AB Dec 16, 2015
500MG

tablet Discontinued ORAL N/A Dec 16, 2015
250MG

tablet Prescription ORAL AB Dec 16, 2015





62. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 5 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Prescription ORAL AB Jan 15, 2009
500MG

tablet Prescription ORAL AB Jan 15, 2009
750MG

tablet Prescription ORAL AB Jan 15, 2009
1GM

tablet Prescription ORAL AB Jan 15, 2009
100MG/ML

solution Discontinued ORAL N/A Nov 20, 2023


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Puducherry Strides Pharma Science Limited
Bangalore Strides Pharma Science Limited





63. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Discontinued ORAL N/A Sep 9, 2013
750MG

tablet, extended release Discontinued ORAL N/A Sep 9, 2013


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Billerica Sun Pharmaceutical Industries, Inc.
India
Vadodara Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Halol Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Mohali Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Bharuch Sun Pharmaceutical Industries Ltd
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Ahmednagar Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Dadra Sun Pharmaceutical Industries Limited
Baruch Sun Pharmaceutical Industries Ltd.





64. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Discontinued INTRAVENOUS N/A Jun 16, 2010





65. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, extended release Discontinued ORAL N/A Sep 12, 2011
750MG

tablet, extended release Discontinued ORAL N/A Sep 12, 2011





66. TARO

Taro Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Prescription ORAL AA Feb 10, 2009
500MG

tablet Prescription ORAL AB Feb 1, 2010
750MG

tablet Prescription ORAL AB Feb 1, 2010
1GM

tablet Prescription ORAL AB Feb 1, 2010
250MG

tablet Prescription ORAL AB Feb 1, 2010


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Honolulu Taro Delight, LLC
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





67. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Discontinued ORAL N/A Jan 15, 2009
500MG

tablet, extended release Discontinued ORAL N/A Sep 12, 2011
750MG

tablet, extended release Discontinued ORAL N/A Sep 12, 2011
1GM

tablet Discontinued ORAL N/A Jan 15, 2009





68. TOLMAR

Tolmar Inc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Tolmar.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML

solution Discontinued ORAL N/A Jan 15, 2009


Manufacturing Plant Locations
New

Tolmar's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Tolmar as present at those locations.

Country City Firm Name
United States
Fort Collins Tolmar, Inc.
Fort Collins TOLMAR Inc.
Windsor TOLMAR, Inc.
Fort Collins TOLMAR 1413 ACQUISITION, LLC





69. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Prescription ORAL AB Jan 15, 2009
500MG

tablet Prescription ORAL AB Jan 15, 2009
750MG

tablet Prescription ORAL AB Jan 15, 2009
1GM

tablet Prescription ORAL AB Jan 15, 2009





70. TORRENT PHARMS LTD

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet, extended release Discontinued ORAL N/A May 29, 2012
500MG

tablet, extended release Discontinued ORAL N/A May 29, 2012





71. VIWIT PHARM

Viwit Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Viwit Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG

tablet Prescription ORAL AB Mar 13, 2009
500MG

tablet Prescription ORAL AB Mar 13, 2009
1GM

tablet Prescription ORAL AB Mar 13, 2009
250MG

tablet Prescription ORAL AB Mar 13, 2009


Manufacturing Plant Locations
New

Viwit Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Viwit Pharm as present at those locations.

Country City Firm Name
China
Tengzhou Viwit Pharmaceutical Co., Ltd.





72. WATSON LABS INC

Watson Laboratories Inc has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM

tablet Discontinued ORAL N/A Jan 15, 2009
250MG

tablet Discontinued ORAL N/A Jan 15, 2009
500MG

tablet Discontinued ORAL N/A Jan 15, 2009
750MG

tablet Discontinued ORAL N/A Jan 15, 2009





73. XGEN PHARMS

Xgen Pharmaceuticals Djb Inc has filed for 1 generic for Levetiracetam. Given below are the details of the strengths of this generic introduced by Xgen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML (100MG/ML)

injectable Prescription INTRAVENOUS AP Aug 5, 2011





74. ZHEJIANG JINGXIN

Zhejiang Jingxin Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Zhejiang Jingxin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Prescription ORAL AB Dec 14, 2010
750MG

tablet Prescription ORAL AB Dec 14, 2010
500MG

tablet Prescription ORAL AB Dec 14, 2010
1GM

tablet Prescription ORAL AB Dec 14, 2010





75. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Levetiracetam. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet Prescription ORAL AB Apr 29, 2009
1GM

tablet Prescription ORAL AB Apr 29, 2009